| Market Research A to Z | Company Profiles A to Z | Register | Contact Us |
| +44 (0) 203 086 8600 Call us on |
Cambodia Pharmaceuticals and Healthcare Report Q3 2010
Market |
Healthcare and Medical |
Report Type |
Market Research |
Country |
Cambodia |
Published |
21 July 2010 |
Number of Pages |
42 |
Download |
|
Immediate |
|
Publisher |
Business Monitor International |
Cambodia’s pharmaceutical market was calculated to be worth KHR711bn (US$172mn) in 2009. We forecast drug consumption to increase at a rate of 11.6% over the next five years to reach a value of KHR1,232bn (US$302mn) in 2014. Our long range forecast is for the market to reach KHR2,062bn (US$516mn) in 2019, equivalent to annual growth of 11.2% over the 10-year period. In absolute terms, the country’s pharmaceutical market is one of the smallest covered by BMI. However, its high growth potential emphasises Cambodia as an emerging target for drugmakers in the medium term. In the Pharmaceutical Business Environment Ratings for Q310, Cambodia is ranked the lowest of the 16 Asia Pacific markets surveyed. The country’s medicine market is small in absolute terms and percapita expenditure is low. However, we are forecasting double-digit growth over the medium term. Fundamental disincentives to drugmakers include a young and predominantly rural population, a lack of respect for intellectual property, endemic corruption and excessive bureaucracy.
A decade of economic growth and political stability has allowed Cambodia to begin to tackle its underdeveloped healthcare system. Measures such as health equity funds, a new social health insurance system and the use of nongovernmental organisations (NGOs) has begun to reduce inequalities in the system. The public health budget has grown in line with economic growth. However, per capita health expenditure remains low and around 60% of healthcare costs are paid out-of-pocket.
Government figures show that the national health budget is increasing. However, contributions from foreign donors exceed government contributions at a rate of around 2:1. This reliance on foreign contributions means that health expenditure levels are exposed to fluctuations in the exchange rate. Counterfeit drugs are a major constraint on legitimate drug market growth. Around 65% of the illegal pharmacies operating in Cambodia have been closed, according to the US Pharmacopeia in May 2010. The development comes as the result of a major anti-counterfeiting operation undertaken by the Cambodian government for over five months. According to figures released by the Cambodian Ministry of Health, the number of illegal pharmacies was reduced from 1,081 to 379 between November 2009 and March 2010.
The domestic pharmaceutical industry comprises seven small manufacturers dealing in basic generic medicines. The bulk of demand is met through imports, both from developed markets (such as France) and nascent markets (such as India, Thailand and Vietnam).
Last Viewed
Cambodia Pharmaceuticals and Healthcare Report Q3 2010High Speed Rail Infrastructure Component Manufacturing
Restoration Hardware, Inc. - Strategic Analysis Review
RuggedCom Inc. (RCM) - Financial and Strategic Analysis Review
Fujikura Ltd. (5803) - Financial and Strategic Analysis Review
Healthcare and Medical Company Profiles
Healthcare and Medical Company Profiles contain up to date financial, strategic, operational, SWOT analysis and product information on the activities of thousands of healthcare and medical companies.
Become an Affiliate
Do you manage an industry specific website or blog? Are you looking to monetise your web traffic further? Are you a B2B website?
Why not offer your visitors industry specific strategic market reports and company profiles? Our Affiliate Program enables you to provide quality content on your website and to earn money from passing on visitors to our website. If a sale is made from your visitor, you earn commission (a fixed percentage of the price of a product).
Custom Research
Cannot find what you need? We can tailor a report for you. Complete the Custom Research Form and we will provide a quote.
News
Genium Bionic Prosthetic System Represents the First Intuitive Knee
AdCare continues nursing facilities acquisitions strategy
AdCare Purchases US$27.3Mn Nursing Facilities in Arkansas to Drive Strong Revenue Growth
Micromet to Develop Blinatumomab with the National Cancer Institute
AstraZeneca to Develop Targacept’s Product Candidate AZD1446 as a Treatment for Alzheimer’s
Market Insights
Currently there are no Market Insights in this sector.
